GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ahn-Gook Pharmaceutical Co Ltd (XKRX:001540) » Definitions » Cyclically Adjusted FCF per Share

Ahn-Gook Pharmaceutical Co (XKRX:001540) Cyclically Adjusted FCF per Share : ₩-284.62 (As of Mar. 2025)


View and export this data going back to 2000. Start your Free Trial

What is Ahn-Gook Pharmaceutical Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Ahn-Gook Pharmaceutical Co's adjusted free cash flow per share for the three months ended in Mar. 2025 was ₩322.184. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ₩-284.62 for the trailing ten years ended in Mar. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Ahn-Gook Pharmaceutical Co was 177.00% per year. The lowest was -7.80% per year. And the median was 16.30% per year.

As of today (2025-05-31), Ahn-Gook Pharmaceutical Co's current stock price is ₩7760.00. Ahn-Gook Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was ₩-284.62. Ahn-Gook Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is .

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Ahn-Gook Pharmaceutical Co was 833.87. The lowest was 19.90. And the median was 57.64.


Ahn-Gook Pharmaceutical Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Ahn-Gook Pharmaceutical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ahn-Gook Pharmaceutical Co Cyclically Adjusted FCF per Share Chart

Ahn-Gook Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 233.78 324.43 258.84 232.77 -326.93

Ahn-Gook Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -413.23 -348.94 -341.49 -326.93 -284.62

Competitive Comparison of Ahn-Gook Pharmaceutical Co's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Ahn-Gook Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ahn-Gook Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ahn-Gook Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Ahn-Gook Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.


;
;

Ahn-Gook Pharmaceutical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ahn-Gook Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=322.184/122.5900*122.5900
=322.184

Current CPI (Mar. 2025) = 122.5900.

Ahn-Gook Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 631.020 100.051 773.175
201509 357.830 100.111 438.178
201512 454.589 100.220 556.055
201603 428.907 100.561 522.864
201606 177.807 100.791 216.264
201609 200.865 101.461 242.694
201612 -175.941 101.561 -212.370
201703 540.004 102.851 643.643
201706 -188.292 102.611 -224.953
201709 -87.888 103.491 -104.108
201712 791.752 102.991 942.423
201803 376.402 104.101 443.254
201806 -26.259 104.130 -30.914
201809 -570.788 105.651 -662.305
201812 -154.214 104.351 -181.169
201903 612.210 104.491 718.252
201906 -55.720 104.881 -65.128
201909 1,150.046 105.200 1,340.150
201912 -110.101 105.121 -128.397
202003 259.407 105.354 301.846
202006 580.811 105.112 677.389
202009 -194.885 106.198 -224.967
202012 -1,286.604 105.765 -1,491.270
202103 -401.374 107.357 -458.325
202106 -173.741 107.579 -197.985
202109 87.771 108.759 98.933
202112 163.325 109.676 182.555
202203 -260.957 111.848 -286.020
202206 -62.793 114.072 -67.482
202209 354.399 114.715 378.727
202212 -203.612 115.179 -216.713
202303 167.602 116.507 176.352
202306 13.195 117.182 13.804
202309 -894.374 118.964 -921.637
202312 47.419 118.837 48.917
202403 -6,699.270 120.123 -6,836.843
202406 132.457 120.007 135.308
202409 364.863 120.861 370.082
202412 -77.769 121.135 -78.703
202503 322.184 122.590 322.184

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Ahn-Gook Pharmaceutical Co  (XKRX:001540) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Ahn-Gook Pharmaceutical Co was 833.87. The lowest was 19.90. And the median was 57.64.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Ahn-Gook Pharmaceutical Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Ahn-Gook Pharmaceutical Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Ahn-Gook Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
993-75, Daerim-Dong, Yeongdeungpo-Gu, Seoul, KOR, 150-072
Ahn-Gook Pharmaceutical Co Ltd manufactures and markets medicines. The company is famous for medicine for ophthalmology. The company also engages in various prescription medicines.

Ahn-Gook Pharmaceutical Co Headlines

No Headlines